Bio-Techne Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TECH research report →
Companywww.bio-techne.com
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies.
- CEO
- Kim Kelderman
- IPO
- 1989
- Employees
- 3,100
- HQ
- Minneapolis, MN, US
Price Chart
Valuation
- Market Cap
- $7.21B
- P/E
- 65.55
- P/S
- 5.96
- P/B
- 3.44
- EV/EBITDA
- 28.16
- Div Yield
- 0.69%
Profitability
- Gross Margin
- 64.96%
- Op Margin
- 12.70%
- Net Margin
- 9.05%
- ROE
- 5.49%
- ROIC
- 4.75%
Growth & Income
- Revenue
- $1.22B · 5.23%
- Net Income
- $73.40M · -56.34%
- EPS
- $0.47 · -56.07%
- Op Income
- $102.25M
- FCF YoY
- 8.66%
Performance & Tape
- 52W High
- $72.16
- 52W Low
- $43.20
- 50D MA
- $52.63
- 200D MA
- $57.69
- Beta
- 1.41
- Avg Volume
- 2.59M
Get TickerSpark's AI analysis on TECH
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 8, 26 | Herr Amy E. | other | 6,636 |
| May 8, 26 | Herr Amy E. | sell | 6,636 |
| May 8, 26 | Herr Amy E. | other | 6,636 |
| May 5, 26 | Hippel James | other | 62,000 |
| May 5, 26 | Hippel James | other | 56,955 |
| May 5, 26 | Hippel James | other | 62,000 |
| May 5, 26 | Bohnen Shane | other | 8,400 |
| May 5, 26 | Bohnen Shane | other | 7,055 |
| May 5, 26 | Bohnen Shane | other | 8,400 |
| May 5, 26 | Kelderman Kim | other | 26,692 |
Our TECH Coverage
We haven't published any research on TECH yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate TECH Report →